The association of Pulmonary Hypertension and right ventricular systolic function -updates in diagnosis and treatment

Link to article at PubMed

Dis Mon. 2023 Sep 19:101635. doi: 10.1016/j.disamonth.2023.101635. Online ahead of print.

ABSTRACT

Right ventricular (RV) systolic function is an essential but neglected component in cardiac evaluation, and its importance to the contribution to overall cardiac function is undermined. It is not only sensitive to the effect of left heart valve disease but is also more sensitive to changes in pressure overload than the left ventricle. Pulmonary Hypertension is the common and well-recognized complication of RV systolic dysfunction. It is also the leading cause of pulmonary valve disease and right ventricular dysfunction. Patients with a high pulmonary artery pressure (PAP) and a low Right ventricular (RV) ejection fraction have a seven-fold higher risk of death than heart failure patients with a normal PAP and RV ejection fraction. Furthermore, it is an independent predictor of survival in these patients. In this review, we examine the association of right ventricular systolic function with Pulmonary Hypertension by focusing on various pathological and clinical manifestations while assessing their impact. We also explore new 2022 ESC/ERS guidelines for diagnosing and treating right ventricular dysfunction in Pulmonary Hypertension.

PMID:37734967 | DOI:10.1016/j.disamonth.2023.101635

Leave a Reply

Your email address will not be published. Required fields are marked *